SBC Medical Group Holdings Incorporated (SBC) Stock Price & Analysis
SBC Medical Group Holdings Incorporated (SBC) — MoonshotScore 94/100 (Exceptional band), calculated Nov 18, 2026. Price $5.60 (-10.69%), as of the Nov 19, 2026 trading session; market cap $574M.
Educational signal · not a buy or sell recommendation · How to read this
SBC Medical Group Holdings Incorporated · SBC · NASDAQ
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers across Japan, Vietnam, and the United States. The company supports franchisees with services ranging from marketing and staff management to clinic construction and IT solutions.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · SBC Medical Group Holdings (SBC)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality and a fortress balance sheet, at a dirt-cheap price, but weak growth; the market is already moving on it. Business Quality: Elite; Financial Safety: Fortress; Valuation: Cheap; Growth Durability: Fading; Momentum: Surging.
- quarterly revenue $59M (Q3 FY2026, quarter ended Sep 2026)
- EPS beat 4 of the last 8 reports
- Altman Z 4.64 · Piotroski F 6
Helping: business quality, balance-sheet strength, an attractive price, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 92 | Exceptional | |
| 88 | Exceptional | |
| 94 | Exceptional | |
| 94 | Exceptional | |
| 94 | Exceptional | |
| 94 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $5.60 | |
| Change on the day | -10.69% | |
| 52-week range | $2.78 – $7.39 | |
| Market capitalisation | $574M | — |
| Price / earnings (trailing) | 12.24 | |
| Shares traded on the day | 497.7K |
Price & events
Other perspectives
Council score for SBC Medical Group Holdings (SBC): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 16, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is SBC Medical Group Holdings (SBC), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. SBC Medical Group Holdings Incorporated (SBC) is listed on NASDAQ. It employs 863 people and is led by Yoshiyuki Aikawa. In Q3 FY2026 it reported revenue of $59M and net income of $16M. The market values it at $574M.
What do the latest results show for SBC Medical Group Holdings (SBC)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of $59M. Against analyst estimates the company has EPS beat 4 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | $59M | $16M | $0.15 (diluted) |
| Q2 FY2026 | $49M | $11M | $0.10 (diluted) |
| Q1 FY2026 | $43M | $11M | $0.11 (diluted) |
| Q4 FY2025 | $40M | $14M | $0.14 (diluted) |
What are the financial strengths and risks for SBC Medical Group Holdings (SBC)?
Short answer · as of
The MoonshotScore pillars rate business quality, balance-sheet strength, an attractive price, positive momentum as strengths. The distress and quality screens read Altman Z 4.64 · Piotroski F 6. Trailing ratios: ROE 19.4% · ROA 12.2% · current ratio 3.67 · earnings yield 6.9% · free-cash-flow yield 13.1%.
What should you watch next at SBC Medical Group Holdings (SBC)?
Short answer · as of
The stored analyst-target capture is expired, so a current target watchpoint is unavailable.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
Checked against the records this page reads, on the dates shown above.
How does SBC Medical Group Holdings compare with its peers?
Short answer
SBC Medical Group Holdings's score ranks 1st of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| SBC Medical Group Holdings (SBC) — this page | $5.60 | $574M | 94 |
| $89.16 Nov 18, 2026 | $4.24B | 90 5-pillar Nov 18, 2026 | |
| $203.52 Nov 19, 2026 | $5.55B | 85 5-pillar Nov 18, 2026 | |
| $82.65 Nov 19, 2026 | $9.80B | 77 5-pillar Nov 18, 2026 | |
| $4.02 Nov 19, 2026 | $22.2M | 77 5-pillar Nov 18, 2026 | |
| $166.51 Nov 19, 2026 | $2.63B | 76 5-pillar Nov 18, 2026 | |
| $74.47 Nov 19, 2026 | $14.2B | 73 5-pillar Nov 18, 2026 | |
| $176.51 Nov 19, 2026 | $20.7B | 72 5-pillar Nov 18, 2026 | |
| $76.45 Nov 19, 2026 | $1.37B | 71 5-pillar Nov 18, 2026 | |
| $217.19 Nov 19, 2026 | $1.36B | 55 5-pillar Nov 18, 2026 | |
| $2.85 Nov 18, 2026 | $56.8M | 53 5-pillar Nov 18, 2026 | |
| $8.54 Nov 19, 2026 | $239M | 46 5-pillar Nov 18, 2026 | |
| $8.76 Nov 19, 2026 | $159M | 46 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Last captured analyst target range, low to high (expired, captured Nov 5, 2026)
- $9.00 – $15.00
- Last captured analyst target (expired, captured Nov 5, 2026)
- $12.00
- Last captured median analyst target (expired, captured Nov 5, 2026)
- $12.00
Historical target record · Captured · Capture expired; not a current watchpoint.
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 10
- Identified insiders
- 3
- Purchases
- 0
- Sales
- 3
- Other transactions
- 7
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held SBC in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported SBC in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about SBC Medical Group Holdings (SBC)?
Common Questions About SBC
These answers are editorial: 1 of these 9 answers is drawn from the SBC research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for SBC?
SBC carries the MoonshotScore stated above — the Exceptional band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers across Japan, Vietnam, and the United States.
Is SBC a good stock to buy?
Stock Expert AI does not rate SBC buy, sell or hold. SBC Medical Group Holdings Incorporated carries a MoonshotScore, in the Exceptional band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the SBC stock price today?
The last price recorded for SBC Medical Group Holdings Incorporated (SBC), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the SBC price target?
The last analyst consensus price target we captured for SBC Medical Group Holdings Incorporated (SBC), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.
What are the main risks for SBC?
SBC Medical Group Holdings Incorporated faces several risks, including increased competition from larger consulting firms and specialized service providers. Economic downturns could negatively impact consumer spending on cosmetic treatments, affecting SBC's revenue and profitability. Changes in consumer preferences and trends in the cosmetic treatment industry could also pose a challenge.
What are the key factors to evaluate for SBC?
SBC Medical Group Holdings Incorporated (SBC) holds a MoonshotScore in the high range. To weigh it, start with the trailing P/E under Price & valuation on this page. Strategic Partnerships with Medical Equipment Suppliers: Forming strategic alliances with leading medical equipment suppliers can provide SBC's franchisees with access to cutting-edge technologies and preferential pricing. Not financial advice.
How frequently does SBC data refresh on this page?
SBC's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven SBC's recent stock price performance?
SBC Medical Group Holdings Incorporated (SBC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established presence in Japan, Vietnam, and the United States. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SBC overvalued or undervalued right now?
The trailing P/E of SBC Medical Group Holdings Incorporated (SBC) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 20 figures on this page — 12 from Financial Modeling Prep (FMP), 7 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com